on-pharmacological therapies in the treatment of breast hardening

Not Applicable

Recruiting

• Conditions: lactation disorders; breast-feeding; postpartum; SP2.006.022

• Registration Number: RBR-6btb6zz
• Lead Sponsor: universidade federal do acre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-12-06
• Study Completion: 2022-03-31
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Women in the lactation period, with the presence of unilateral or bilateral breast engorgement, primiparae or multiparae, coming from vaginal or cesarean delivery, hospitalized in the hospital or seeking guidance and/or care at the Human Milk Bank present at the aforementioned institution.

Exclusion Criteria

Women with a possible picture or finding of puerperal breast mastitis, women who have breast implants, presence of neoplastic process, women who did not sign the free and informed consent form and who were unable to sustain a minimum time of five minutes for the procedure.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in pain level assessed using a visual analogue pain scale (VAS) and breast engorgement using a six-point scale immediately and 30 minutes after each procedure.

Secondary Outcome Measures

Name	Time	Method
Absence of ultrasound-induced overheating lesion in the breast region, as assessed using an infrared camera, model E6 (Flir Systems Inc., Wilconville, USA), with the camera lens positioned 40 cm from the surface of the breasts.